Ascendis Pharma A/S annual operating expenses
2019
2020
2021
2022
2023
2024
2025
Ascendis Pharma A/S Operating Expenses Growth & History (ASND)
Ascendis Pharma A/S's operating expenses was €761.5M for fiscal 2025.
View full Ascendis Pharma A/S company overviewAscendis Pharma A/S annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €761.5M | €163.3M | +27.31% |
| 2024 | 2024-12-31 | €598.1M | −€79.7M | −11.76% |
| 2023 | 2023-12-31 | €677.9M | €77.0M | +12.82% |
| 2022 | 2022-12-31 | €600.9M | €144.8M | +31.75% |
| 2021 | 2021-12-31 | €456.0M | €118.5M | +35.10% |
| 2020 | 2020-12-31 | €337.6M | €97.5M | +40.60% |
| 2019 | 2019-12-31 | €240.1M | — | — |
Ascendis Pharma A/S quarterly operating expenses
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €91.2M | −€88.4M | −49.23% |
| Q1 2026 | 2026-03-31 | €204.3M | €16.6M | +8.86% |
| Q4 2025 | 2025-12-31 | €214.0M | €54.5M | +34.16% |
| Q3 2025 | 2025-09-30 | €180.3M | €36.9M | +25.74% |
| Q2 2025 | 2025-06-30 | €179.5M | €21.8M | +13.79% |
| Q1 2025 | 2025-03-31 | €187.6M | €50.2M | +36.50% |
| Q4 2024 | 2024-12-31 | €159.5M | €4.7M | +3.01% |
| Q3 2024 | 2024-09-30 | €143.4M | −€31.7M | −18.10% |
| Q2 2024 | 2024-06-30 | €157.8M | −€17.5M | −9.99% |
| Q1 2024 | 2024-03-31 | €137.5M | −€35.2M | −20.38% |
| Q4 2023 | 2023-12-31 | €154.9M | −€10.3M | −6.25% |
| Q3 2023 | 2023-09-30 | €175.1M | €17.0M | +10.72% |
| Q2 2023 | 2023-06-30 | €175.3M | €28.3M | +19.28% |
| Q1 2023 | 2023-03-31 | €172.7M | €42.0M | +32.19% |
| Q4 2022 | 2022-12-31 | €165.2M | €51.2M | +44.94% |
| Q3 2022 | 2022-09-30 | €158.1M | €60.1M | +61.25% |
| Q2 2022 | 2022-06-30 | €147.0M | €28.3M | +23.86% |
| Q1 2022 | 2022-03-31 | €130.6M | €5.2M | +4.16% |
| Q4 2021 | 2021-12-31 | €114.0M | — | — |
| Q3 2021 | 2021-09-30 | €98.0M | — | — |
| Q2 2021 | 2021-06-30 | €118.7M | — | — |
| Q1 2021 | 2021-03-31 | €125.4M | — | — |
Ascendis Pharma A/S operating expenses trends
Over the last five fiscal years, Ascendis Pharma A/S's operating expenses increased from €337.6M to €761.5M, a change of €423.9M. The latest reported quarter, Q2 2026, shows €91.2M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ascendis Pharma A/S source filings ↗